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Abstract 
A reagentless glutamate biosensor was applied to the determination of glutamate released 
from liver hepatocellular carcinoma cells (HepG2) in response to toxic challenge from 
various concentrations of paracetamol. A screen printed carbon electrode (SPCE) containing 
the electrocatalyst Meldola’s Blue (MB-SPCE) served as the electron mediator for the 
oxidation of NADH.  
A mixture of the enzyme glutamate dehydrogenase (GLDH), cofactor nicotinamide adenine 
dinucleotide (NAD
+
) and the biopolymer chitosan (CHIT) were drop-coated onto the surface 
of the transducer (MB-SPCE) in a simple one step fabrication process.  
The reagentless biosensor was used with amperometry in stirred solution at an applied 
potential of +0.1 V (vs. Ag/AgCl). All experiments were carried out at the following 
conditions: pH 7, temperature 37ºC, atmosphere 5% CO2.  
The linear range of the device was found to be 25 – 125 μM in phosphate buffer (75 mM, 
containing 0.05 M NaCl) and 25 – 150 μM in cell culture medium. The limits of detection 
(LOD) were found to be 1.2 µM and 4.2 µM based on three times signal to noise, using PBS 
and culture medium respectively. The sensitivity was calculated to be 106 nA µM
-1 
cm
-2
 and 
210 nA µM
-1
 cm
-2 
in PBS and cell medium respectively. The response time was ~60s in an 
agitated solution.  
HepG2 cells were exposed to various concentrations of paracetamol (1 mM, 5 mM and 10 
mM) in order to investigate the drug-induced release of glutamate into the culture medium in 
real time. Two toxicity studies were investigated using different methods of exposure and 
analysis.  
The first method consisted of a single measurement of the glutamate concentration, using the 
method of standard addition, after 24 hours incubation. The concentrations of glutamate were 
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found to be 52µM, 93µM and 177µM, released on exposure to 1mM, 5mM and 10mM 
paracetamol respectively.  
The second method involved the continuous monitoring of glutamate released from HepG2 
cells upon exposure to paracetamol over  8 hours. The concentrations of glutamate released in 
the presence of 1mM, 5mM and 10mM paracetamol, increased in proportion to the drug 
concentration, ie: 16µM, 28µM and 62µM respectively. This result demonstrates the 
feasibility of using this approach to monitor early metabolic changes after exposure to a 
model toxic compound. 
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1. Introduction 
 
Glutamate is the primary excitatory neurotransmitter in the mammalian central nervous 
system [1] and also has a central role in cell metabolism and function [2]. Glutamate is 
associated with processes such as protein synthesis/degradation, ammonia disposal, energy 
production and neurotransmission [3], thus glutamate plays a significant role  in fundamental 
metabolic processes. As a result, glutamate is present in many cells such as skeletal muscle, 
liver, intestine and kidneys. Specifically, glutamate plays vital roles in hepatic metabolic 
pathways such as ureagenesis, gluconeogenesis and glutathione synthesis [4]. 
The concentration of intracellular glutamate is typically higher than that of extracellular 
glutamate. For example, within the brain, extracellular glutamate concentrations are normally 
within the 1 – 10 µM range [5,6] whilst intracellular glutamate concentrations are typically in 
the micromolar range [7]. Similar micromolar levels have been observed intracellularly in rat 
livers [8,9].  
Drug discovery is a costly and extensive process, with product development comprising up to 
30 – 35% of the cost of bringing a new pharmaceutical compound to the market [10]. Early 
candidates for drug development are selected based on their pharmacological and 
toxicological properties which are investigated through early-stage in vitro cell-based assays 
[11]. Cytotoxicity assays such as neutral red, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide), LDH (lactate dehydrogenase) leakage, and protein assays are 
commonly used to evaluate the effects of drugs on cell metabolism and death [12]. However, 
these are employed by sampling off-line, or as end-point assays, and do not provide 
information on early toxicity events in real-time.  In an approach using electrochemical 
biosensors to address the issue of continuous analyte monitoring in vitro, Pemberton et. al. 
[13,14] have described the development and application of a screen-printed microband 
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biosensor to follow glucose uptake by HepG2 cells in the presence of  different 
concentrations of paracetamol.  
Some reports have described the use of chitosan for the immobilization of glutamate 
dehydrogenase on glassy carbon [15–18], gold [19] and platinum [20] electrodes. Both 
reagentless and non-reagentless conventional sized glutamate biosensors have previously 
been developed by drop-coating the required biomolecules onto the working electrode of a 
screen-printed carbon electrode [21–23]. We have recently reviewed electrochemical 
glutamate biosensor construction and their applications in food and clinical analysis [24]. 
Modified Chitosan has been utilised for the covalent immobilization of glutamate oxidase 
[25] and lactate oxidase [26], however, as far as we are aware, there are no examples of the 
use of chitosan to fabricate screen-printed microband glutamate biosensors. In this paper we 
explore this latter possibility and demonstrate the application of the proposed device for real-
time monitoring of toxicity, through the metabolic changes (glutamate release) caused by the 
addition of paracetamol.  
2. Materials and Methods 
 
2.1. Chemicals and Reagents 
Foetal bovine serum (FBS), Minimum Essential Medium Eagle (EMEM) and all other 
chemicals were purchased from Sigma-Aldrich. All chemicals were of analytical grade, 
purchased from Sigma Aldrich, UK, except glutamate dehydrogenase (CAT: 10197734001) 
which was purchased from Roche, UK. The 75 mM phosphate buffer (PB) was prepared by 
combining appropriate volumes of tri–sodium phosphate dodecahydrate, sodium dihydrogen 
orthophosphate dihydrate and disodium hydrogen orthophosphate anhydrous solutions to 
yield the desired pH. Glutamate and NADH/NAD
+
 solutions were dissolved directly in 75 
mM PB. Chitosan was dissolved in 0.05 M HCl (pH < 3.0) to produce a 0.05% solution 
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following up to 10 minutes sonication. A 25 mM stock solution of glutamate (monosodium 
glutamate) was utilised for glutamate calibrations. A 500 mM stock of paracetamol in 100% 
ethanol was diluted with cell culture media and filtered sterilised (0.2µm) before use.  
2.2. Apparatus 
All electrochemical experiments were conducted with a two electrode system consisting of a 
carbon working electrode containing MB (MB–SPCE, Gwent Electronic Materials Ltd; Ink 
Code: C2030519P5), and a Ag/AgCl reference electrode (The difference between  the screen-
printed Ag/AgCl electrode and the conventional Ag/AgCl (3M NaCl) was +80mV) (GEM 
Product Code C61003P7); both printed onto PVC (poly vinyl chloride). The electrodes were 
connected to the potentiostat using gold clips. Microband electrodes/biosensors and reference 
electrodes were held by gold clips attached to cork lids which were push-fitted into 6-well 
plate wells (Corning®). Electrodes were connected to a PG580RM 5-channel potential 
(Uniscan Instruments Ltd, Buxton, UK; www.uniscan.com) which was controlled using 
UiEChem software (Version 2.02), for both single and multiple parallel well experiments. All 
cell culture work and dosing with paracetamol was conducted under a sterile conditions. The 
cork lid electrode holders was sterilised with 70% ethanol spray. The electrodes themselves 
were not sterilised as the ethanol  would potentially damage the enzyme and cofactor. 
Experiments utilising culture medium and HepG2 cells were carried out in an incubator with 
a 5% CO2
 
atmosphere at 37ºC in order to maintain the correct pH. Sonications were 
performed with a Devon FS100 sonicator (Ultrasonics, Hove, Sussex, UK). 
2.3. Principle of operation of the biosensor  
The overall principle of operation of the biosensor is shown in Figure 1. Glutamate in 
solution is oxidised to form 2-oxoglutarate in the presence of the immobilised enzyme 
glutamate dehydrogenase (GLDH) and NAD
+
; the products NADH and NH4
+
 are formed 
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during this reaction. NADH chemically reduces Meldola's Blue which subsequently 
undergoes electrochemical oxidation at the electrode surface to produce the analytical 
response. 
2.4. Biosensor Fabrication 
The fabrication procedure is illustrated in Figure 2. Five microliters of CHIT (0.05% in 
0.05M HCl) were drop-coated onto the surface of a 3 mm
2
 working electrode (a), followed by 
9µL of GLDH (3U/µL) and 1µL of NAD+ (106µg) (b). The biosensor was then left to dry 
overnight at 4ºC (c). Once dried, insulating tape was used to cover the working area and some 
of the electrode track (d). Microbiosensors were formed by cutting through the working 
electrode using scissors to expose a 3mm-long working electrode edge (e).  
2.5. Electron Microscopy 
The microband biosensor was attached to a 9 mm-diameter double sided adhesive carbon disc 
on a 45º angled aluminium stub. A cross section of the edge of the electrode was examined 
using a Philips XL30 environmental scanning electron microscope (ESEM).  
2.6. HepG2 cell culture 
The HepG2 (Human Caucasian Hepatocyte Carcinoma) cell line (obtained from European 
Collection of Authenticated Cell Cultures, ECACC) was cultured as a monolayer in 75 cm
2
 
flasks, in a 5% CO2-in-air atmosphere at 37 °C, at an initial density of 2 x10
5
 cells cm
−2
.  
Cells were counted using a haemocytometer. The culture medium was EMEM containing 
10% FBS, 1% non-essential amino acids (NEAA), 200 nM L-glutamine. When confluent, the 
cells were detached by trypsinisation, and resuspended in culture medium. For the assays 
described, cells were plated at a density of 2 x 10
6
 cells mL
−1
 in 6 mL volumes into 6-well 
tissue culture plates.  
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2.7. Voltammetry and amperometry 
All cyclic voltammetric studies were carried out by lowering a microband biosensor, in 
combination with a screen-printed Ag/AgCl reference electrode, into the voltammetric cell 
containing a 10 ml solution of 75 mM phosphate containing 50 mM NaCl (PBS).  For studies 
with NADH, the following procedure was employed: phosphate buffer solution was carried 
out in the presence and absence of oxygen, followed by 15s equilibration at open circuit 
voltage. The working electrode potential scanned from an initial potential of -0.5 V to the 
switching potential, +0.6V, at a scan rate of 5 mVs
-1
.  
All of the studies involved the use of six-well plates containing appropriate control or test 
solutions which were agitated using a gyrorotator at a fixed speed which ensured thorough 
mixing of the cells with paracetamol.  Gyrorotation of the plates was maintained for the 
duration of the experiments.  All amperometric measurements were carried using an applied 
potential of +0.1V. A calibration study was performed using culture media. Additions of 
glutamate were made so that the final concentrations in the solution were in the range of 25 - 
150µM. All studies were carried out at pH 7.4.  
2.8. Real-time monitoring of glutamate in cell culture medium in the 
presence/absence of cells and toxic compounds. 
HepG2 cells grown in T75 flasks, once 80% confluent were trypsinized and transferred to six 
well tissue culture plates, along with 6mls of cell medium under sterile conditions. 24 hours 
were allowed to pass to allow the cells to fully adhere to the bottom of the wells. Appropriate 
aliquots of paracetamol (from 100 mM in 20% ethanol, diluted with cell culture medium) 
were then exchanged for medium in order to achieve the desired final concentrations in a 6ml 
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volume.  The cork lids which held the microband glutamate biosensor and reference electrode 
were push-fitted into each well. A small (1 mm diameter) hole in the top surface of each 
sensor cork lid allowed air to escape, avoided pressure build-up during the push-fitting step 
and allowed for gaseous exchange to maintain the pH of the media.  
The electrode leads were extended from the inside of the incubator through the temperature 
seal and connected to respective channels of the multichannel potentiostat. The 6-well plate 
was rotated utilising a gyro-rotator within an incubator at 37 °C, 5% CO2 in the air 
atmosphere. An operating potential of +0.1 V vs Ag/AgCl was applied to each working 
electrode, and the instrument was run in amperometric mode for 8 hours for the real-time 
experiments. The resulting data were exported into Microsoft Excel and plotted as current-
versus-time graphs.  
3. Results and Discussion 
3.1. Microband Biosensor 
An SEM image of the edge of a microband biosensor is shown in Fig 3. The image is labelled 
to indicate the layers of the individual components. The thickness of the original Meldola’s 
Blue screen printed working electrode was 20 µm. The area of the exposed edge of the 
microband electrode was 60,000
 µm2 (3 mm x 20 µm).  
3.2. Cyclic voltammetric behaviour of NADH using a microband biosensor. 
Cyclic voltammograms were obtained with the microband biosensors in a solution containing 
NADH, 75 mM PBS pH 7; a scan rate of 5 mVs
-1
 was used. Typical cyclic voltammetric 
responses for NADH are shown in Fig 4. The spikes present on the voltammogram arise from 
the silver redox reaction due to the silver contained within the ink. In the presence of NADH 
the responses show sigmoidal and steady state behaviour; these show that an increase in the 
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anodic peak potential occurred with increasing concentrations of NADH. This behaviour is 
indicative of the electro-catalytic oxidation of NADH [27] and is a pre-requisite for 
applications in monitoring glutamate.  
The steady state currents resulting from this electrocatalytic behaviour are obtained for both 
deoxygenated (Figure 4) and oxygenated (Supp Figure 1) solutions of NADH and are very 
similar. It may also be noted, at a voltage of +0.5V, there is an observed rise in the anodic 
current, this arises owing to the potential being sufficiently positive to cause the direct 
oxidation of NADH at the carbon particles of the modified screen printed electrode. We have 
observed this second oxidation in previous work for NADH at MB-SPCE [27]. It appears that 
although small cathodic peaks appear in Figure 4, they are considerably smaller in the 
absence of oxygen compared to those in the presence of oxygen. This is clearer by referring 
to the blank red CV (oxygen present) compared to the blue CV (oxygen absent). This we 
believe can be explained by the presence of a small concentration of residual oxygen in the 
solution, following the deoxygenation procedure. An applied potential of +0.1V was chosen 
for the operation of the biosensor, in order to avoid oxidising interferences that may be 
present within complex cell media.   
3.3. Calibration studies of glutamate in cell culture medium using a microband 
biosensor and operational stability. 
Fig 5A shows an amperogram obtained with different glutamate concentrations using the 
microband biosensors in agitated culture medium at an applied potential of +0.1V (versus 
Ag/AgCl).  Each arrow indicates the addition of an aliquot of 6 µL of a 25 mM glutamate 
stock solution into 6 mLs of culture medium. The corresponding calibration plot is shown in 
Fig 5B. The standard deviations represented are based on n = 5 runs using separate 
biosensors. The biosensor, functioning in cell media, possessed the following characteristics: 
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linear range, 25 – 150 µM; sensitivity, 0.13 nA/µM; and a theoretical limit of detection of 
4.24 µM (based on three times signal to noise). At this point the biosensor assay appears to be 
suitable for our proposed real time cell toxicity studies.  
The operational stability of the biosensor was investigated over a period of 8 hours. The 
microband biosensor was inserted into an agitated cell media solution containing 100µM of 
glutamate and after steady state had been reached an aliquot of paracetamol (10mM) was 
added to the solution. Supplementary Figure 2 demonstrates that the addition of paracetamol 
does not influence the magnitude of the glutamate response over a period of 8 hours. This 
observation is important for the studies described in the following sections (3.4/3.5).  
3.4. Glutamate determination in cell culture medium after 24 hours’ exposure of 
HepG2 cells to various concentrations of paracetamol.  
Fully confluent HepG2 cells were exposed to various concentrations of paracetamol (1 mM, 5 
mM and 10 mM) for 24 hours. After exposure, the cell medium was collected and the cells 
were disposed of. The microband biosensor was initially immersed in untreated cell medium, 
and once a steady-state baseline was achieved the biosensor was transferred to the post-
exposure cell media. This resulted in an increase in current as a result of the additional 
glutamate released by the HepG2 cells. Once steady-state had been reached, standard 
additions of 25 mM glutamate were added to the cell. The response generated by the 
endogenous glutamate present in the cell medium and the additions of glutamate were plotted 
against concentration. From this standard addition plot, the original concentration of 
glutamate found in the cell media was determined.  
The average endogenous concentrations for glutamate released from the HepG2 cells were 52 
µM (CoV: 13.74%, n = 3), 93 µM (CoV: 18.41%, n = 3) and 177 µM (CoV: 14.54% n = 3) 
for 1 mM, 5 mM, 10 mM doses of paracetamol respectively. A bar chart (Fig 6) illustrates the 
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relationship between increasing paracetamol concentration, and increased release of 
glutamate. The data shown for each concentration of paracetamol is based on the 
determination of the glutamate concentration released into the culture medium of three 
separately treated flasks of HepG2. The standard deviations shown are based on n = 3. 
3.5. Real-time monitoring of glutamate release from HepG2 cells exposed to various 
concentrations of paracetamol.  
Fully confluent HepG2 cells in six well plates were incubated with various concentrations of 
paracetamol (1 mM, 5 mM and 10 mM) as described above. Microband biosensors were 
placed into the wells within 5 minutes of paracetamol addition; the release of glutamate was 
then monitored in real time over an 8 hour period at the applied potential of +0.1V. Figure 7 
illustrates an example of the currents generated as a result of glutamate released from the 
HepG2 cells and monitored by the  glutamate biosensors for each concentration of 
paracetamol.  As with the previous method, each repeat is based on a separate analysis of 
HepG2 cells.  
The concentrations of glutamate in the wells at the end of the 8 hour experiment were 
determined from a calibration plot. The relationship between the glutamate concentration 
released after 8 hours, and the concentrations of paracetamol is shown in Figure 8. The 
following values have been obtained; 15 µM (1mM, CoV: 2.4%, n =3), 28 µM (5mM ,CoV: 
1.96%, n = 3) and 62 µM (10mM, CoV: 5.79%, n = 3), indicating high reproducibility. 
Clearly, the increase in the current due to the release of glutamate correlates with the 
increasing paracetamol concentration. The mechanism behind the release of glutamate is 
likely to be due to the Phase I and Phase II metabolism of paracetamol by the enzyme 
CYP450 present within HepG2 cells. CYP450 typically converts paracetamol to the toxic by-
product N-acetyl-p-benzoquinone imine (NAPQI). At sub-lethal concentrations of 
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paracetamol, glutathione conjugates the NAPQI to a non-harmful product. However, at 
higher doses of paracetamol the glutathione is unable to regenerate sufficiently to process the 
NAPQI [28]. NAPQI subsequently binds to membrane proteins [29][30], resulting in hepatic 
necrosis, which leads to the rupture of the cell membrane and release of its contents. With 
increasing concentrations of paracetamol, the number of liver cells undergoing hepatic 
necrosis will increase, resulting in the release of glutamate from the cells. The extent to 
which the glutamate is released scales accordingly with the increasing concentrations of 
paracetamol metabolised by the cells. 
The advantage of monitoring the cells in real time is that it is possible to determine the length 
of time taken for the paracetamol to have an effect upon the metabolism of the HepG2 cells. 
As shown in Fig. 7, it appears to take 1 hour (3600s) for glutamate to begin to be released 
from the cells and this timing seems to be independent of the drug concentration. The average 
timing for the glutamate release is as follows (n = 3); 1mM – 2916s, 5mM – 2666 s and 
10mM – 3566 s. After 7 hours the currents begin to reach steady state, suggesting that the 
release of glutamate from the cells has ceased.  
4. Conclusions 
This paper has described the successful development and application of an amperometric, 
reagentless, glutamate microband biosensor. We believe that this is achieved by a 
combination of mainly crosslinking and partial entrapment of the biocomponents onto the 
surface of the working electrode using the biopolymer, chitosan. The former occurs through 
interaction of the amine groups of chitosan with the carboxyl groups of glutamate 
dehydrogenase; a similar suggestion has been made by Baker et.al [31]. The entrapment 
process is likely to involve partial diffusion of the enzyme/cofactor layer into the chitosan 
layer, which subsequently forms a hydro-gel. It should be mentioned that in the absence of 
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chitosan on the surface of the biosensor, non-steady-state currents were obtained in response 
to additions of glutamate (Supp Fig 3.). This may be attributed to the poor immobilization of 
the enzyme/cofactor on the surface of the screen-printed electrode and highlights the 
importance of the chitosan layer.  
The device has been successfully applied to the determination of glutamate released by 
HepG2 cells in response to toxic challenge by paracetamol. The device was used to determine 
the concentration of glutamate released by cells into the culture media after 24 hours by 
standard addition. The microband biosensor was also applied to the real-time monitoring of 
glutamate released by cells over 8 hours.  In repeat experiments, the toxicity induced release 
of glutamate from the HepG2 cells resulted in currents which corresponded with the 
concentrations of paracetamol utilised. We observed a high level of repeatability with each 
study, as highlighted by the low coefficients of variation achieved. The experimental setup 
(37ºC in an incubator with a 5% CO2 atmosphere) reduced the likelihood of inaccuracy by 
maintaining a steady temperature, pH and a favourable environment for the cell media/cells.  
The monitoring of real time metabolic events by using an electrochemical microband 
biosensor holds great potential for further development. The simple drop-coating fabrication 
procedure involving the entrapment of the biocomponents by chitosan, and the simple cutting 
technique to fabricate the micro biosensor, could be a potential platform for developing other 
microband biosensors based on dehydrogenase enzymes.  
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Figure Captions  
Figure 1: Schematic displaying interaction between the enzyme glutamate dehydrogenase, 
cofactor NAD
+
 and the analyte glutamate at the surface of the electrode, resulting in the 
subsequent generation of the analytical response. 
Figure 2: Scheme showing the various steps involved in the fabrication of the reagentless 
glutamate biosensor. a) Drop coating of CHIT b) drop coating of GLDH and NAD
+
 c) drying 
d) application of insulating tape across working area of electrode e) cutting through working 
electrode to expose the micro biosensor.  
Figure 3. SEM image of the cross section of the microband biosensor electrode. The layers 
are described as follows; 1) PVC Substrate 2) MB-SPCE 3) CHIT 4) GLDH/NAD
+ 
5) 
Insulating Tape  
Figure 4: Cyclic voltammograms of a reagentless glutamate biosensor in the presence and 
absence of 2.5 and 5 mM NADH (PBS, pH 7.4, oxygenated and deoxygenated solution) 
Figure 5: A) Amperogram carried out with the reagentless glutamate micro biosensor in cell 
media. Each arrows indicate an aliquot of 6µL of a 25mM glutamate stock solution into 
6mLs of cell media. B) Resulting calibration plot. Each point represents the mean current 
response for n=3 runs +/- 1SD. 
Figure 6: Bar chart illustrating the concentrations of glutamate present in cell media 
following 24 hours’ incubation in the presence of various concentrations of paracetamol. 
Each plot represents the mean current response for n = 3 runs +/- 1SD. 
Figure 7: Amperograms generated by reagentless glutamate microband biosensors monitoring 
the glutamate released by HepG2 cells incubated with various concentrations of paracetamol 
(1 mM, 5 mM, 10 mM). 3600s = 1 hour.   
Figure 8:  Bar chart illustrating the currents generated as a result of glutamate generated after 
8 hours of incubation in the presence of various concentrations of paracetamol in real time, n 
= 3, +/- 1SD 
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